Tristel Share News (TSTL)

IN BRIEF: Tristel CEO Paul Swinney sells GBP350,000 in shares

Tristel PLC - Cambridgeshire-based maker of infection prevention products - Chief Executive Officer Paul Swinney sells 100,000 shares at 350 pence each, worth GBP350,000, in London on Thursday. Swinney is now interested in 312,350 shares, a 0.66% stake.

Tristel annual revenue and profit up thanks to robust demand

(Alliance News) - Tristel PLC on Tuesday said it expects to see annual revenue and profit ahead of expectations, driven by robust demand.

UK earnings, trading statements calendar - next 7 days

Director dealings: Tristel non-exec buys first shares, LSE buyback continues

(Sharecast News) - On the list of director buys on Monday was Tristel, after a non-executive director spent almost £30k on shares.

LONDON MARKET MIDDAY: Stocks green amid UK service sector strength

(Alliance News) - Stock prices in London were higher at midday on Monday as markets looked to further positive news for the UK's service sector.

AIM WINNERS & LOSERS: Tristel hails FDA approval of ULT disinfectant

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Tristel shares soar amid US FDA approval for ultrasound disinfectant

(Alliance News) - Tristel PLC on Monday said it was granted approval from the US Food & Drug Administration for its ultrasound disinfectant for immediate sale.

Numis starts coverage of Tristel at 'add'

(Sharecast News) - Numis started coverage of Tristel on Thursday with an 'add' rating and 390p price target.

LONDON BROKER RATINGS: Numis starts Tristel with 'add'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Broker tips: Fevertree,Tristel

(Sharecast News) - Liberum hiked its price target on Fevertree Drinks on Thursday to 1,500p from 1,000p following an update from the posh tonic maker.

TRADING UPDATES: Sabien works with Empiric; Coro sells in Italy

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Tristel books strong first-half as it enters North America markets

(Sharecast News) - Infection prevention developer Tristel reported a 16% increase in first-half revenue on Monday, to £17.5m, driven by 21% growth in underlying revenue.

Tristel swings to half-year profit as revenue growth outpaces costs

(Alliance News) - Tristel PLC on Monday reported that it swung to an interim profit in the six months to December 31, as its disinfectant foam De Novo could be approved by the US Food & Drug Administration.

UK earnings, trading statements calendar - next 7 days

Tristel returning to pre-pandemic growth trajectory

(Sharecast News) - Infection prevention product developer Tristel said in an update on Monday that it was returning to its "pre-pandemic growth trajectory", with first-half revenue set to top £17m, compared to £15m in the same period last year.